Preclinical CRO Market - By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), By Region & Global Forecast, 2023 - 2032

Preclinical CRO Market - By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), By Region & Global Forecast, 2023 - 2032

Preclinical CRO Market is slated to grow at a robust rate through 2032 owing to the increasing usage of drugs during preclinical trials given the rising cases of chronic diseases and an increasing demand for effective treatment for the same. Besides, various biotechnology and pharmaceutical companies, quite often, opt for outsourcing to attain the medical needs for preclinical validations to fasten up the whole process. This has significantly propelled the number of drugs entering the preclinical phase.

Overall, the preclinical CRO market has been bifurcated in terms of end-use, service, and region.

Within the service segment, the others subsegment is slated to grow at a steady rate of more than 7% CAGR through the estimated timeframe. The other services in the preclinical CRO market comprise bioavailability testing, bioequivalence testing, drug-interaction testing services, etc.

Based on end-use, the preclinical CRO market has been divided into government & academic institutes, biopharmaceutical companies, medical device companies, and others. Among them, the government & academic institutes segment held more than 14.5% market share in 2022. The growth can be primarily attributed to the increasing number of research and R&D activities that are outsourced to academic institutes. Besides, academic institutes and the governments are also providing diagnosis and access to treatments under preclinical trials, which is likely to propel the preclinical CRO industry growth in the upcoming time.

In the regional landscape, the preclinical CRO market has been broadly categorized into North America, Europe, LATAM, MEA, and Asia Pacific. Among them, the preclinical CRO market in the Asia Pacific region is anticipated to grow at a steady rate over the estimated timeframe. The increasing geriatric population in this region and rising cases of chronic diseases like diabetes, cancer, and cardiac diseases are anticipated to supplement the market growth.

Additionally, an increase in the number of investigational compounds and ongoing preclinical trials in oncology in Asia Pacific will boost the preclinical CRO business size in this region.

Meanwhile, the preclinical CRO market in the LATAM region is also slated to grow at a robust rate through the analysis timeframe. The healthcare infrastructure in this region is well-developed and it also boasts a well-established regulatory environment. These factors enable Latin America to be a fertile landscape to allow preclinical research to be conducted easily.

Some of the key companies operating in the preclinical CRO market are Laboratory Corporation of America Inc., Charles River Laboratory Inc., Pharmaceutical Product Development (PPD) LLC, ICON plc, Eurofins Scientific, Parexel International Corporation, Medpace, Inc., WuXi AppTec, SGS SA, Altasciences Company, Inc.


Chapter 1 Methodology
1.1 Methodology
1.2 Market scope and definition
1.3 Base estimates
1.4 Forecast calculations
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Secondary
1.7.1.1 Paid sources
1.7.1.2 Unpaid sources
1.7.2 Primary
Chapter 2 Executive Summary
2.1 Preclinical CRO industry 360 degree synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Service trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 Preclinical CRO Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing R&D expenditure worldwide
3.3.1.2 Growing outsourcing of R&D activities
3.3.1.3 Rising number of drugs in preclinical trails
3.3.2 Industry pitfalls & challenges
3.3.2.1 Stringent regulatory policies
3.4 Growth potential analysis
3.4.1 By service
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Preclinical trial volume analysis
3.6.1 preclinical trial volume analysis, by region, 2018 - 2021
3.6.2 preclinical trial volume analysis, by indication, 2018 - 2021
3.6.3 preclinical trial volume analysis, by phase of development, 2018 - 2021
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Asia Pacific
3.7.3.1 Singapore
3.7.3.2 Malaysia
3.7.3.3 Indonesia
3.7.3.4 Thailand
3.7.3.5 South Korea
3.7.3.6 Philippines
3.8 Clinical trials- Asia Pacific advantage
3.9 Pricing Landscape
3.10 Industry ecosystem analysis
3.11 Drug discovery and development process
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Strategic dashboard, 2022
4.5 Merger & acquisition landscape
4.5.1 Merger & acquisition deals in the CRO industry, 2018 - 2022
4.5.2 Completed contract research organization merger & acquisition deals, 2018-2021
4.5.3 Influence of private equity in CRO mergers & acquisitions
4.5.3.1 PRA Health Sciences
4.5.3.2 Medpace, Inc.
4.5.3.3 PPD, Inc.
4.5.3.4 Parexel International Corporation
4.5.4 Impact of industry consolidation on the overall market
4.5.5 Analyst insights
Chapter 5 Preclinical CRO Market, By Service
5.1 Key segment trends
5.2 Bioanalysis & DMPK studies
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Toxicology testing
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Others
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Preclinical CRO Market, By End-use
6.1 Key segment trends
6.2 Biopharmaceutical companies
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Government and academic institutes
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Medical devices companies
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Preclinical CRO Devices Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
Chapter 8 Company Profiles
8.1 Charles River Laboratory, Inc.
8.2 Laboratory Corporation of America, Inc.
8.3 Pharmaceutical Product Development (PPD), LLC (a part of Thermo Fisher Scientific),
8.4 ICON plc
8.5 Eurofins Scientific
8.6 Parexel International Corporation
8.7 Medpace, Inc.
8.8 WuXi AppTec
8.9 SGS SA
8.10 Altasciences Company, Inc.
Data Tables
TABLE 1. Global preclinical CRO market, 2018 - 2022 (USD Million)
TABLE 2. Global preclinical CRO market, 2023 - 2032 (USD Million)
TABLE 3. Global preclinical CRO market, by service, 2018 - 2022 (USD Million)
TABLE 4. Global preclinical CRO market, by service, 2023 - 2032 (USD Million)
TABLE 5. Global preclinical CRO market, by end-use, 2018 - 2022 (USD Million)
TABLE 6. Global preclinical CRO market, by end-use, 2023 - 2032 (USD Million)
TABLE 7. Global preclinical CRO market, by region, 2018 - 2022 (USD Million)
TABLE 8. Global preclinical CRO market, by region, 2023 - 2032 (USD Million)
TABLE 9. Industry impact forces
TABLE 10. Mergers and acquisitions landscape, 2018 - 2022
TABLE 11. Bioanalysis & DMPK studies market size, by region, 2018 - 2022 (USD Million)
TABLE 12. Bioanalysis & DMPK studies market size, by region, 2023 - 2032 (USD Million)
TABLE 13. Toxicology testing market size, by region, 2018 - 2022 (USD Million)
TABLE 14. Toxicology testing market size, by region, 2023 - 2032 (USD Million)
TABLE 15. Others market size, by region, 2018 - 2022 (USD Million)
TABLE 16. Others market size, by region, 2023 - 2032 (USD Million)
TABLE 17. Biopharmaceutical companies market size, by region, 2018 - 2022 (USD Million)
TABLE 18. Biopharmaceutical companies market size, by region, 2023 - 2032 (USD Million)
TABLE 19. Government & academic institutes market size, by region, 2018 - 2022 (USD Million)
TABLE 20. Government & academic institutes market size, by region, 2023 - 2032 (USD Million)
TABLE 21. Medical device companies market size, by region, 2018 - 2022 (USD Million)
TABLE 22. Medical device companies market size, by region, 2023 - 2032 (USD Million)
TABLE 23. Others market size, by region, 2018 - 2022 (USD Million)
TABLE 24. Others market size, by region, 2023 - 2032 (USD Million)
TABLE 25. North America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
TABLE 26. North America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
TABLE 27. North America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 28. North America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 29. North America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 30. North America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 31. U.S. preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 32. U.S. preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 33. U.S. preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 34. U.S. preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 35. Canada preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 36. Canada preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 37. Canada preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 38. Canada preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 39. Europe preclinical CRO market size, by country, 2018 - 2022 (USD Million)
TABLE 40. Europe preclinical CRO market size, by country, 2023 - 2032 (USD Million)
TABLE 41. Europe preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 42. Europe preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 43. Europe preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 44. Europe preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 45. Germany preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 46. Germany preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 47. Germany preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 48. Germany preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 49. UK preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 50. UK preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 51. UK preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 52. UK preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 53. France preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 54. France preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 55. France preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 56. France preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 57. Italy preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 58. Italy preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 59. Italy preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 60. Italy preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 61. Spain preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 62. Spain preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 63. Spain preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 64. Spain preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 65. Asia Pacific preclinical CRO market size, by country, 2018 - 2022 (USD Million)
TABLE 66. Asia Pacific preclinical CRO market size, by country, 2023 - 2032 (USD Million)
TABLE 67. Asia Pacific preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 68. Asia Pacific preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 69. Asia Pacific preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 70. Asia Pacific preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 71. Japan preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 72. Japan preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 73. Japan preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 74. Japan preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 75. China preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 76. China preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 77. China preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 78. China preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 79. India preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 80. India preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 81. India preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 82. India preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 83. Australia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 84. Australia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 85. Australia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 86. Australia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 87. Latin America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
TABLE 88. Latin America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
TABLE 89. Latin America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 90. Latin America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 91. Latin America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 92. Latin America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 93. Brazil preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 94. Brazil preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 95. Brazil preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 96. Brazil preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 97. Mexico preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 98. Mexico preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 99. Mexico preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 100. Mexico preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 101. MEA preclinical CRO market size, by country, 2018 - 2022 (USD Million)
TABLE 102. MEA preclinical CRO market size, by country, 2023 - 2032 (USD Million)
TABLE 103. MEA preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 104. MEA preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 105. MEA preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 106. MEA preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 107. South Africa preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 108. South Africa preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 109. South Africa preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 110. South Africa preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
TABLE 111. Saudi Arabia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
TABLE 112. Saudi Arabia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
TABLE 113. Saudi Arabia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
TABLE 114. Saudi Arabia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
Charts & Figures
FIG 1. Top-down approach
FIG 2. Breakdown of primary participants
FIG 3. Preclinical industry 360 degree synopsis, 2018 - 2032
FIG 4. Industry segmentation
FIG 5. Industry landscape, 2018-2032 (USD Million)
FIG 6. Growth potential analysis, by service
FIG 7. Growth potential analysis, by end-use
FIG 8. Industry ecosystem analysis
FIG 9. Drug discovery and development process
FIG 10. Company matrix analysis, 2022
FIG 11. Strategy dashboard, 2022
FIG 12. Key segment trends, by service
FIG 13. Key segment trends, by end-use
FIG 14. Key regional trends

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings